Bridgewater Associates’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,162
Closed -$1.01M 749
2023
Q1
$1.01M Buy
23,162
+788
+4% +$34.8K 0.01% 560
2022
Q4
$835K Sell
22,374
-7,359
-25% -$285K ﹤0.01% 663
2022
Q3
$1.18M Sell
29,733
-103
-0.3% -$3.81K 0.01% 668
2022
Q2
$1.14M Buy
29,836
+3,813
+15% +$138K ﹤0.01% 781
2022
Q1
$1.03M Buy
26,023
+7,525
+41% +$295K ﹤0.01% 796
2021
Q4
$768K Sell
18,498
-3,777
-17% -$164K ﹤0.01% 614
2021
Q3
$939K Sell
22,275
-862
-4% -$43.4K 0.01% 523
2021
Q2
$1.06M Buy
+23,137
New +$1.1M 0.01% 578

Other funds holding NRC

Bridgewater Associates's NRC Position: Q2 2023 in Review

Bridgewater Associates sold out of NRC Health Common Stock (NRC) in Q2 2023, closing a stake of 23,162 shares — an estimated $1.01M sold.

Bridgewater Associates first reported a position in NRC in Q2 2021 and held it in 8 quarters. The position peaked at $1.18M in Q3 2022. 116 funds tracked by Wall St. Rank hold NRC as of Q2 2023.

  • Bridgewater Associates reported no remaining NRC Health Common Stock position as of Q2 2023 after selling out during the quarter.
  • Bridgewater Associates sold 23,162 NRC Health Common Stock shares in Q2 2023, an estimated $1.01M.
  • Bridgewater Associates first reported a position in NRC Health Common Stock in Q2 2021 and held it in 8 quarters.
  • Bridgewater Associates's NRC Health Common Stock position peaked at $1.18M in Q3 2022.
  • 116 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2023.

Based on Bridgewater Associates's 13F filing for Q2 2023, filed 11 Aug 2023.